Michael Perrone, MD
Orthopaedic Surgery · Los Angeles, CANPI 1568875987
Payments from drug & device makers
Across 235 payments — averaging $428.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Micromed Inc$38K
- Arthrex$31K
- Stryker$9K
- Vericel Corporation$9K
- Smith+Nephew$8K
- Saxum Surgical, Inc.$3K
- plus $3K from 9 others
What the payments were for
- Consulting fees$5,5005%
- Grants$21,94422%
- Travel & lodging$13,31513%
- Food & beverage$10,44610%
- Education$49,48049%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Micromed Inc | 38 | $38,477 |
| Arthrex | 63 | $30,633 |
| Stryker | 74 | $8,996 |
| Vericel Corporation | 4 | $8,930 |
| Smith+Nephew | 29 | $7,642 |
| Saxum Surgical, Inc. | 5 | $2,737 |
| DJO, LLC | 4 | $1,944 |
| Medical Device Business Services, Inc. | 7 | $856 |
| Bioventus LLC | 3 | $170 |
| Team_makena_llc | 1 | $109 |
| Globus Medical | 2 | $81 |
| Johnson & Johnson | 2 | $61 |
| Biotissue Holdings Inc. | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Acumed LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MACI$8,917
- VARIAX$1,917
- AUGMENT INJECTABLE$1,652
- AXSOS$1,505
- HOFFMANN$1,505
- GAMMA$1,505
- SPATIAL FRAME$996
- NOVOSTITCH$996
- NA$943
- Biosure$893
- FLEXIBLE GUIDE PIN (STRYKER ACL VERSITOMIC)$777
- GRYPHON$747
- ACUFEX Meniscal Root Repair$733
- AIR$655
- PROCINCH$621
- ICONIX$485
- CINCHLOCK SS$390
- ALLOGRAFT BIO-IMPLANTS$332
- SALVATION$323
- Actishield$319
How this compares
$100,686 in reported general payments places this provider in the 90th percentile of 1,808 orthopaedic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other orthopaedic surgery in Los Angeles
- Kelly VinceLos Angeles$9.6M
- Jay LiebermanLos Angeles$4.8M
- Thomas SchmalzriedLos Angeles$4M
- David ThordarsonLos Angeles$2.6M
- David SkaggsLos Angeles$2.6M
- Edward McPhersonLos Angeles$1.3M
- Andrew SpitzerLos Angeles$1.2M
- Daniel AllisonLos Angeles$1.1M
- Charles MoonLos Angeles$986K
- Justin SalimanLos Angeles$948K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.